Real Estate Investors Are Buying a Record Share of U.S. Homes
Investors bought 18.4% of the U.S. homes that were purchased in the fourth quarter, worth…
News
HQ Launches NY Business Travel Barometer Predicting a Steady Recovery for Corporate Travel From 24% of Pre-Pandemic Levels in January 2022 to 40% by April 2022
In January, only 18% of employees were at the office but Business Travel Barometer predicts…
Leading Multinational Law Firm Harvey Law Group Opens First U.S. Office in Miami
Firm builds U.S. presence in response to strong, ongoing demand for services from those in…
Cindy Roark, DMD, Joins Harvard School of Dental Medicine Board of Fellows
Senior Vice President & Chief Clinical Officer of Sage Dental partners with the prestigious group…
Perimeter Medical Imaging AI Announces Conference Call and Webcast to Provide Corporate Update
Live Call/Webcast on Wednesday, February 23, 2022 at 5 pm ET TORONTO & DALLAS–(BUSINESS WIRE)–$PINK.V…
GoHenry 2022 Youth Economy Report Reveals New Earning Habits of Kids in the U.S.
Gen Z and Gen Alpha are finding innovative ways to earn more money, such as…
Qualtrics Announces Discover, Defining the Next Generation of Experience Management
New set of products helps organizations listen to, analyze and act on everything that customers…
Worldwide Market for Foldable Phones Forecast to Reach 27.6 million Units With a Market Value of $29 Billion in 2025, According to IDC
NEEDHAM, Mass.–(BUSINESS WIRE)–#FlipPhone–International Data Corporation (IDC) witnessed worldwide shipments of foldable phones, inclusive of both…
Bakkt Study Examines Loyalty & Rewards Preferences of Digital Assets Among U.S. Consumers
Study validates rising tide of consumer interest in crypto rewards ALPHARETTA, Ga.–(BUSINESS WIRE)–Bakkt Holdings, Inc….
New Cloud Security Alliance Report Highlights Factors to Consider When Designing Blockchain Solutions That Operate Within Critical Sectors
Paper provides insights into the three layers of distributed ledger technology and how they interact…
Verity Pharmaceuticals™ and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo® and Valchlor® in Puerto Rico
Verity Pharmaceuticals™ and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo® and Valchlor®…
SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
BOSTON and LAUSANNE, Switzerland, Feb. 16, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH),…
PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation
TORONTO, Feb. 16, 2022 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
IsoPlexis to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
BRANFORD, Conn., Feb. 16, 2022 (GLOBE NEWSWIRE) — IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell…
Calithera to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA),…
atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in Psychedelic Medicine
– Leading non-profit and commercial organizations in psychedelic science united in visions to heal mental…
Cerevel Therapeutics to Report Fourth Quarter 2021 Financial Results and Pipeline Update on Tuesday, March 1, 2022
CAMBRIDGE, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated…
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ET PORTLAND, Maine, Feb….
Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2021 Results and Corporate Update
CAMBRIDGE, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome…
European Commission Approves Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older
The first sickle hemoglobin polymerization inhibitor approved in Europe, Oxbryta increases hemoglobin levels and reduces…